Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Alzheimer’s research uncovers a new therapeutic pathway for the memory-robbing malady

Alzheimer’s research uncovers a new therapeutic pathway for the memory-robbing malady

Hormone therapy type may influence postmenopausal cognitive health

Hormone therapy type may influence postmenopausal cognitive health

Routine eye exams may help detect Alzheimer’s years before symptoms appear

Routine eye exams may help detect Alzheimer’s years before symptoms appear

Study offers guidance for communicating with loved ones living with dementia

Study offers guidance for communicating with loved ones living with dementia

New light-based therapy shows promise for improving cognitive function in Alzheimer’s

New light-based therapy shows promise for improving cognitive function in Alzheimer’s

Having a sense of purpose linked to lower dementia risk

Having a sense of purpose linked to lower dementia risk

Research uncovers key role of the brain's blood flow dynamics in Alzheimer’s disease

Research uncovers key role of the brain's blood flow dynamics in Alzheimer’s disease

Mediterranean-style diet may reduce dementia risk in individuals with high genetic risk

Mediterranean-style diet may reduce dementia risk in individuals with high genetic risk

Modest gift card boosts enrollment of low-income participants in Alzheimer’s registry

Modest gift card boosts enrollment of low-income participants in Alzheimer’s registry

Research shows how lysosomes respond to stress

Research shows how lysosomes respond to stress

Midkine found to prevent Alzheimer’s-related protein assemblies

Midkine found to prevent Alzheimer’s-related protein assemblies

Metabolic syndrome linked to higher risk of Parkinson's disease

Metabolic syndrome linked to higher risk of Parkinson's disease

Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS

Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS

New genetic study reveals why people age differently

New genetic study reveals why people age differently

Women with Alzheimer's show reduced levels of healthy unsaturated fats

Women with Alzheimer's show reduced levels of healthy unsaturated fats

RNA quality control protein PELOTA found to slow aging and extend lifespan

RNA quality control protein PELOTA found to slow aging and extend lifespan

Alzheimer’s gene risks differ by ancestry, major study reveals 133 new variants

Alzheimer’s gene risks differ by ancestry, major study reveals 133 new variants

Brain organoids reveal early changes in familial Alzheimer’s disease

Brain organoids reveal early changes in familial Alzheimer’s disease

New discovery in spinal cord neurons offers hope for breathing recovery

New discovery in spinal cord neurons offers hope for breathing recovery

New computer model provides detailed look at mouse brain vasculature

New computer model provides detailed look at mouse brain vasculature

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.